PRLB Share Price | Proto Labs, Inc. Stock Analysis & Recommendation

Q: What does Proto Labs, Inc. do?

Overview:Proto Labs, Inc. is an e-commerce driven digital manufacturer of on-demand 3D printed, CNC machined, and injection-molded custom parts, operating within the Specialty Chemicals industry and classified as a micro-cap company.Financial Snapshot:Most recent Net Sales: 126 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 4 Million (Quarterly Results - Mar 2025) Market-cap: USD 906.85 Million (Micro Cap)Key Metrics:P/E: 44.00 Dividend Yield: 0.00% Debt Equity: -0.15 Return on Equity: 3.12% Price to Book: 1.38Contact Details:Address: 5540 Pioneer Creek Dr, MAPLE PLAIN MN: 55359-9003 Tel: ['1 763 4797474', '1 763 4797726'] Fax: 1 763 4792679 Website: https://www.protolabs.com/

Q: Is Proto Labs, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Proto Labs, Inc. has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the daily moving averages also reflect bullish momentum. However, the KST shows a mildly bearish signal on the weekly timeframe. There is no clear trend indicated by Dow Theory or the OBV for both weekly and monthly periods. In terms of performance, Proto Labs has outperformed the S&P 500 year-to-date and over the past year, with returns of 23.51% and 27.05% respectively, compared to the S&P 500's 16.30% and 19.89%. However, over the longer 3-year and 5-year periods, it has significantly underperformed the benchmark. Overall, the current technical stance is mildly bullish, with mixed signals from various indicators.

Q: Is Proto Labs, Inc. overvalued or undervalued?

As of 28 November 2025, the valuation grade for Proto Labs, Inc. has moved from very expensive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 44, an EV to EBITDA of 13.93, and a Price to Book Value of 1.39. In comparison, peers such as Genesis Energy LP have a significantly higher P/E of 126.33, while Ecovyst, Inc. shows a much lower P/E of 18.34, indicating a broad range of valuations within the sector.In terms of recent performance, Proto Labs has outperformed the S&P 500 on a year-to-date basis, returning 27.99% compared to the S&P 500's 16.45%. However, over the longer term, the company has struggled, with a 5-year return of -63.30% versus the S&P 500's 88.25%. This mixed performance reinforces the notion that while the company is currently fairly valued, its historical performance raises some concerns.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

182.95 k

Shareholding (Dec 2025)

FII

11.13%

Held by 104 FIIs

DII

43.34%

Held by 51 DIIs

Promoter

0.07%

How big is Proto Labs, Inc.?

22-Jun-2025

As of Jun 18, Proto Labs, Inc. has a market capitalization of 906.85 million, with net sales of 499.20 million and a net profit of 14.93 million over the latest four quarters. Shareholder's funds are 670.15 million, and total assets amount to 768.67 million.

View full answer

What does Proto Labs, Inc. do?

22-Jun-2025

Proto Labs, Inc. is a digital manufacturer specializing in on-demand 3D printing, CNC machining, and injection molding of custom parts. As of March 2025, it reported net sales of $126 million and a market cap of approximately $906.85 million.

View full answer

Who are in the management team of Proto Labs, Inc.?

22-Jun-2025

As of March 2022, the management team of Proto Labs, Inc. includes Mr. Sven Wehrwein (Independent Chairman), Ms. Victoria Holt, and six Independent Directors: Mr. Archie Black, Mr. Sujeet Chand, Ms. Moonhie Chin, Dr. Rainer Gawlick, and Mr. John Goodman.

View full answer

Is Proto Labs, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Proto Labs, Inc. shows a mildly bullish trend with mixed technical signals, having outperformed the S&P 500 year-to-date and over the past year, but underperformed over the longer 3- and 5-year periods.

View full answer

Is Proto Labs, Inc. overvalued or undervalued?

02-Dec-2025

As of November 28, 2025, Proto Labs, Inc. is fairly valued with a P/E ratio of 44, an EV to EBITDA of 13.93, and a Price to Book Value of 1.39, despite having underperformed over the past five years with a return of -63.30% compared to the S&P 500's 88.25%, although it has outperformed the index year-to-date with a return of 27.99%.

View full answer

Compare Proto Labs, Inc. with Similar Stocks

Mativ Holdings, Inc.Westlake Chemical Partners LP TETRA Technologies, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Company has a low Debt to Equity ratio (avg) at times

Poor long term growth as Operating profit has grown by an annual rate -20.91% of over the last 5 years

Positive results in Jun 25

With ROE of 3.12%, it has a expensive valuation with a 1.39 Price to Book Value

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

USD 1,313 Million (Small Cap)

P/E

60.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.19

Return on Equity

3.26%

Price to Book

1.96

Revenue and Profits:

Net Sales:

136 Million

(Quarterly Results - Dec 2025)

Net Profit:

6 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

9.14%

6 Months

14.14%

1 Year

59.95%

2 Years

66.9%

3 Years

81.86%

4 Years

9.12%

5 Years

-51.55%

Proto Labs, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

4.18%

EBIT Growth (5y)

-15.23%

EBIT to Interest (avg)

26.91

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.15

Sales to Capital Employed (avg)

0.75

Tax Ratio

34.92%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

4.16%

ROE (avg)

3.35%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.96

EV to EBIT

45.26

EV to EBITDA

19.76

EV to Capital Employed

2.18

EV to Sales

2.22

PEG Ratio

27.20

Dividend Yield

ROCE (Latest)

4.81%

ROE (Latest)

3.26%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 67 Schemes (45.36%)

Foreign Institutions

Held by 104 Foreign Institutions (11.13%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.81% vs 0.22% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -16.67% vs 63.64% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "136.50",
          "val2": "135.40",
          "chgp": "0.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.90",
          "val2": "17.30",
          "chgp": "-8.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.90",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.00",
          "val2": "7.20",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "56.70%",
          "val2": "65.40%",
          "chgp": "-0.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.43% vs -0.60% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 27.71% vs -3.49% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "533.10",
          "val2": "500.90",
          "chgp": "6.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.00",
          "val2": "61.30",
          "chgp": "-2.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.10",
          "val2": "-5.60",
          "chgp": "80.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.20",
          "val2": "16.60",
          "chgp": "27.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.10%",
          "val2": "50.90%",
          "chgp": "-0.18%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

136.50

135.40

0.81%

Operating Profit (PBDIT) excl Other Income

15.90

17.30

-8.09%

Interest

0.00

Exceptional Items

-0.90

-0.00

Consolidate Net Profit

6.00

7.20

-16.67%

Operating Profit Margin (Excl OI)

56.70%

65.40%

-0.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.81% vs 0.22% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -16.67% vs 63.64% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

533.10

500.90

6.43%

Operating Profit (PBDIT) excl Other Income

60.00

61.30

-2.12%

Interest

0.00

0.20

-100.00%

Exceptional Items

-1.10

-5.60

80.36%

Consolidate Net Profit

21.20

16.60

27.71%

Operating Profit Margin (Excl OI)

49.10%

50.90%

-0.18%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 6.43% vs -0.60% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 27.71% vs -3.49% in Dec 2024

All Annual Results

Company CV

About Proto Labs, Inc.

Proto Labs, Inc.

Specialty Chemicals

Proto Labs, Inc. is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company's geographic segments include the United States, Europe and Japan. The Company targets its products to the product developers and engineers who use 3D computer-aided design (3D CAD) software to design products across a range of end markets. Its product lines include Injection Molding, CNC Machining and 3D Printing. Its Injection Molding product line is used for prototype, on-demand and short-run production. Its CNC Machining product line uses commercially available CNC machines to cut plastic or metal blocks into one or more custom parts. Its 3D Printing product line includes stereolithography (SL), selective laser sintering (SLS) and direct metal laser sintering (DMLS) processes. The Company also provides low-volume sheet metal fabrication services.

Company Coordinates

Company Details

5540 Pioneer Creek Dr , MAPLE PLAIN MN : 55359-9003

Tel: 1 763 47974741 763 4797726

https://www.protolabs.com/

Registrar Details